Nplate 500 MCG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FMEA9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,627
Award facts
- Contract value 100% obligated
- $25,627.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,627.45 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 500 microgram vials of Nplate. The delivery order was issued on December 8, 2025, with an ultimate completion date of December 30, 2025, and carries no set-aside designation. This award was issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499,999,999 master contract established on November 13, 2025, to serve as a critical pharmaceutical supplier for Department of Defense healthcare operations.
The PPV-G GEN V initiative represents a $30.3 billion federal acquisition strategy designed to provide comprehensive pharmaceutical supply chain support to military healthcare facilities worldwide. DMS Pharmaceutical Group's single-award contract under this program authorizes the company to supply a broad portfolio of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables under firm fixed-price delivery orders. The company's established track record supplying specialized pharmaceutical products ranging from oncology treatments to emergency medications positions it to fulfill the diverse medical supply requirements of the Department of Defense healthcare system through December 31, 2036.
Quick answers
Who was awarded contract SPE2DR26FMEA9?
SPE2DR26FMEA9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FMEA9 worth?
The government has obligated $25,627 on SPE2DR26FMEA9.
Is contract SPE2DR26FMEA9 an order under another contract?
Yes. SPE2DR26FMEA9 is a delivery order under SPE2DR25D9114, an indefinite delivery contract.
Was contract SPE2DR26FMEA9 competed?
The extent of competition for SPE2DR26FMEA9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award